399 — Innovative Pharmaceutical Biotech Share Price
Last trade - 00:00- HK$361.87m
- HK$2.29bn
- HK$8.08m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 47.22 | ||
| EV to EBITDA | 7.33 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 30.97% | ||
| Return on Equity | n/a | ||
| Operating Margin | 4058.17% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 18.59 | 14.58 | 15.19 | 11.14 | 8.07 | n/a | n/a | -12.57% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Innovative Pharmaceutical Biotech Limited is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The Company operates through five segments. Genetic Testing Services segment is engaged in the provision of genetic testing services in the People’s Republic of China (PRC) and Hong Kong. Bio-Industrial Products segment is engaged in the distribution of bio-industrial products in the PRC. Beauty Equipment and Products segment is engaged in the trading of beauty equipment and products in Hong Kong. Securities Investment segment is engaged in securities investment in Hong Kong and outside Hong Kong. Research and Development segment is engaged in the research, development and commercialization of the oral insulin products.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- March 1st, 2013
- Public Since
- July 18th, 2008
- No. of Employees
- 20
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,723,193,024
- Address
- Room 2111, West Tower, Shun Tak Centre
- Web
- http://www.ipb.asia
- Phone
- +852 null25986818
- Auditors
- Elite Partners CPA Limited
Upcoming Events for 399
Similar to 399
Aceso Life Science
Stock Exchange of Hong Kong Limited
Acme International Holdings
Stock Exchange of Hong Kong Limited
Best Linking group
Stock Exchange of Hong Kong Limited
Bortex Global
Stock Exchange of Hong Kong Limited
CALB Co
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:11 UTC, shares in Innovative Pharmaceutical Biotech are trading at HK$0.21. This share price information is delayed by 15 minutes.
Shares in Innovative Pharmaceutical Biotech last closed at HK$0.21 and the price had moved by +3.96% over the past 365 days. In terms of relative price strength the Innovative Pharmaceutical Biotech share price has outperformed the FTSE Developed Asia Pacific Index by +3.15% over the past year.
There is no consensus recommendation for this security.
Innovative Pharmaceutical Biotech does not currently pay a dividend.
Innovative Pharmaceutical Biotech does not currently pay a dividend.
Innovative Pharmaceutical Biotech does not currently pay a dividend.
To buy shares in Innovative Pharmaceutical Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.21, shares in Innovative Pharmaceutical Biotech had a market capitalisation of HK$361.87m.
Here are the trading details for Innovative Pharmaceutical Biotech:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 399
Based on an overall assessment of its quality, value and momentum Innovative Pharmaceutical Biotech is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Innovative Pharmaceutical Biotech. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -8.58%.
As of the last closing price of HK$0.21, shares in Innovative Pharmaceutical Biotech were trading -5.1% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Innovative Pharmaceutical Biotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.21.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Innovative Pharmaceutical Biotech's directors